Type / Class
Equity / Ordinary Shares, par value CHF 0.05 per share
Shares outstanding
66.4M
Number of holders
39
Total 13F shares, excl. options
17.7M
Shares change
+1.14M
Total reported value, excl. options
$84.1M
Value change
+$5.49M
Number of buys
21
Number of sells
-11
Price
$4.76

Significant Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q3 2025

42 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q3 2025.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.7M shares of 66.4M outstanding shares and own 26.6% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), AKRE CAPITAL MANAGEMENT LLC (3.72M shares), BANQUE PICTET & CIE SA (2.21M shares), Alta Wealth Advisors LLC (1.41M shares), PRINCIPAL FINANCIAL GROUP INC (1.39M shares), Archon Capital Management LLC (427K shares), Bank Pictet & Cie (Europe) AG (255K shares), MILLENNIUM MANAGEMENT LLC (226K shares), FEDERATED HERMES, INC. (210K shares), and EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.